首例报道的他汀类药物诱导的免疫介导坏死性肌病家族病例，伴有抗羟基-3-甲基戊二酰-CoA 还原酶自身抗体和 HLA DRB1*11:01

IF 1.6 4区医学 Q2 Medicine

Acta Clinica Belgica Pub Date : 2024-09-16 DOI:10.1080/17843286.2024.2403694

M. Bronchain, L. Pothen, L. Taihi, A. Cordenier, V. Van Parys

引用次数: 0

摘要

免疫介导的坏死性肌病（IMNM）是一种罕见的自身免疫性肌炎，其特征是对称性肌肉疼痛、近端无力、血清 CK 水平升高以及病理发现的新...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The first reported familial case of statin-induced immune-mediated necrotizing myopathy associated with anti-hydroxy-3-methylglutaryl-CoA reductase autoantibodies and HLA DRB1*11:01

Immune-mediated necrotizing myopathy (IMNM) is a rare type of auto-immune myositis, characterized by symmetric muscle pain, proximal weakness, elevated serum CK levels and pathologic findings of ne...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta Clinica Belgica 医学-医学：内科

CiteScore

2.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, clinical chemistry, pathology and molecular biology, provided they describe results which contribute to our understanding of clinical problems or describe new methods applicable to clinical investigation. Readership includes physicians, pathologists, pharmacists and physicians working in non-academic and academic hospitals, practicing internal medicine and its subspecialties.